{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0003-7125",
      "generic_name": "nivolumab and relatlimab-rmbw",
      "labeler_name": "E.R. Squibb & Sons, L.L.C.",
      "brand_name": "OPDUALAG",
      "active_ingredients": [
        {
          "name": "NIVOLUMAB",
          "strength": "12 mg/mL"
        },
        {
          "name": "RELATLIMAB",
          "strength": "4 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0003-7125-11",
          "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11)  / 20 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20220318",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "E.R. Squibb & Sons, L.L.C."
        ],
        "rxcui": [
          "2596778",
          "2596784"
        ],
        "spl_set_id": [
          "b22c9d83-3256-4e17-85f7-f331a504adc6"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191260",
          "N0000191259",
          "N0000194003",
          "N0000194002"
        ],
        "pharm_class_epc": [
          "Programmed Death Receptor-1 Blocking Antibody [EPC]",
          "Lymphocyte Activation Gene-3 Blocker [EPC]"
        ],
        "pharm_class_moa": [
          "Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
          "Lymphocyte Activation Gene-3 Antagonists [MoA]"
        ],
        "unii": [
          "31YO63LBSN",
          "AF75XOF6W3"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION",
      "spl_id": "7c285448-d5b9-4eca-b117-0d791b1b4de3",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20220318",
      "product_id": "0003-7125_7c285448-d5b9-4eca-b117-0d791b1b4de3",
      "application_number": "BLA761234",
      "brand_name_base": "OPDUALAG",
      "pharm_class": [
        "Lymphocyte Activation Gene-3 Antagonists [MoA]",
        "Lymphocyte Activation Gene-3 Blocker [EPC]",
        "Programmed Death Receptor-1 Blocking Antibody [EPC]",
        "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
      ]
    }
  ]
}